RE/MAX Holdings (FRA:2RM) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:2RM RE/MAX Holdings Inc FRA:2RM
66 GF Score
Price €8.50
GF Value €6.77
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is RE/MAX Holdings Research & Development?

RE/MAX Holdings FRA:2RM +3.28% 66 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:2RM with a GF Score™ of 66/100 and a GF Value™ of €6.77 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. RE/MAX Holdings's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

RE/MAX Holdings  (FRA:2RM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

RE/MAX Holdings Research & Development Related Terms

RE/MAX Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for RE/MAX Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RE/MAX Holdings Research & Development Chart

RE/MAX Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RE/MAX Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:2RM
66GF Score
RE/MAX Holdings Inc FRA:2RM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RE/MAX Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
RE/MAX Holdings (FRA:2RM) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on RE/MAX Holdings and its competitors.
Is RE/MAX Holdings' Research & Development too high?
RE/MAX Holdings' current Research & Development is €0.0 Mil. Overall, RE/MAX Holdings has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RE/MAX Holdings' Research & Development compare to NEN and DOUG?
RE/MAX Holdings' Research & Development of €0.0 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Real Estate company?
A good Research & Development depends on the Real Estate industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on RE/MAX Holdings and its competitors. RE/MAX Holdings's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RE/MAX Holdings stock overvalued right now?
Based on GuruFocus' analysis, RE/MAX Holdings (FRA:2RM) is currently considered Modestly Overvalued. The stock's GF Value™ is €6.77, compared to a current price of €8.50 — trading 25.6% above its estimated fair value. The current Research & Development is €0.0 Mil. RE/MAX Holdings' overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For RE/MAX Holdings (FRA:2RM), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RE/MAX Holdings (FRA:2RM) Overvalued in 2026?

Based on GuruFocus' analysis, RE/MAX Holdings stock appears to be overvalued. The current stock price of €8.50 is trading 25.6% above its estimated GF Value™ of €6.77. GuruFocus considers RE/MAX Holdings to be Modestly Overvalued.

Key valuation signals for FRA:2RM:

  • Research & Development: €0.0 Mil
  • GF Value™: €6.77 vs. price of €8.50 (25.6% above fair value)
  • GF Score™: 66/100 with 8 warning signs

No single metric tells the full story. See the FRA:2RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RE/MAX Holdings Business Description

Other Exchanges RMAX:USA
Address 5075 South Syracuse Street, Denver, CO, USA, 80237
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
66GF Score

Get the complete analysis for FRA:2RM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.50
Price
€6.77
GF Value